Subscribe to Newsletter
Subspecialties Cornea / Ocular Surface

Ahead of the Curve

With a growing need for donor corneas, researchers are looking for new ways to meet tissue demand. Enter the self-curving cornea. Created by a team at Newcastle University’s Institute of Genetic Medicine – responsible for the first 3D printed cornea – these ‘self-curving’ biological tissues take just five days to develop. In the study, a flat circle of stromal cells – derived from limbal rings left over from corneal transplantation – were activated by a serum that caused the edges of the circle to contract at a different rate to the cells at the center. The result is a bowl-shaped structure similar to that of a human cornea.

So how did the idea come about? “A few years ago, we discovered that a particular peptide amphiphile had an RGD sequence similar to that of collagen, and that cells recognize peptides in that sequence and, as a result, bind readily to them.” explains Che Connon, Professor of Tissue Engineering at the University. “We were making a gel of the RGD peptide amplifier and found that cells didn’t contract very much – even in the presence of serum, whereas cells in a collagen gel without peptides will readily contract in a serum medium,” says Connon. “We then thought if you can spatially localize the peptides within a 3D gel, then you can infer shape into the contraction.” And that’s what they did. Indeed, the team spent a lot of time investigating the effect that shape has on corneal cell function.

“The curvature isn’t just important for refractive purposes. Recent papers have shown that corneal stromal cells actually change their type if they are grown in a curved environment. The cells have developed and evolved within a curved material and only behave appropriately (by which I mean, form aligned collagen, which is the structural part of the cornea) in a curved environment,” explains Connon. “And that’s why we created two forms of hydrogel – one that the cells can bind to and pull against, and another where the cells can’t. If you position those hydrogels next to each other within a contiguous system, you will find that one half of the overall hydrogel will contract and the other half will not – it is this combination that infers a shape overall.”  

Though there are other ways of manufacturing corneas, such as 3D printing, a relatively simple approach to generating transplantable corneas is advantageous, says Connon. Though the concept is still in its infancy, the team hopes that the principle can be applied elsewhere in the body. “Imagine a tubular vessel, which could contract in response to certain factors flowing through that tube – like a stent placed into the heart,” says Connon.

“Just the idea of being able to create complex shaped tissues in response to external environment is a game changer.”

Receive content, products, events as well as relevant industry updates from The Ophthalmologist and its sponsors.

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

About the Author
Phoebe Harkin

Associate Editor of The Ophthalmologist

I’ve always loved telling stories. So much so, I decided to make a job of it. I finished a Masters in Magazine Journalism and spent three years working as a creative copywriter before itchy feet sent me (back)packing. It took seven months and 13 countries, but I’m now happily settled on The Ophthalmologist, where I’m busy getting stuck into all things eyeballs.

Related Case Studies
The Missing Piece of the Dry Eye Puzzle

| Contributed by Quidel

Uncovering Ocular Comorbidity

| Contributed by Quidel

Finding Ocular Surface Inflammation

| Contributed by Quidel

Related Product Profiles
Subspecialties Cornea / Ocular Surface
Tear Osmolarity – Empowering. Established. Essential.

| Contributed by TearLab

Subspecialties Cornea / Ocular Surface
Preservative-Free Cyclosporine 0.1% Ophthalmic Emulsion

| Contributed by ImprimisRx

Product Profiles

Access our product directory to see the latest products and services from our industry partners

Here
Most Popular
Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: